Furthermore, our results indicated that anorexigenic IGF1 signaling occurs within the hypothalamus and that hyperinsulinemia-induced insulin resistance coincided with IGF1 resistance, potentially revealing a new mechanism contributing to obesity. This evidence concerns the gene IGF1 and hyperinsulinism.